fluoxetine has been researched along with Cancer of Liver in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon carcinoma (cc)." | 8.31 | Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines. ( Arteta, B; Curzytek, K; Grygier, B; Kubera, M; Maes, M; Malicki, S, 2023) |
| "Fluoxetine, an antidepressant, has been indicated to elicit anti-cancer response in hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) in vitro." | 7.96 | Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model. ( Chiang, IT; Hsu, FT; Hsu, LC; Tu, HF; Yueh, PF, 2020) |
| "The aim of the present study was to verify the effects of fluoxetine on dysregulation of apoptosis and invasive potential in human hepatocellular carcinoma (HCC) SK-Hep1 and Hep3B cells." | 7.91 | Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro. ( Chen, CH; Chen, WT; Hsu, FT; Hsu, LC; Lin, SS; Liu, YC, 2019) |
| " We investigated the apoptotic effect of fluoxetine against the Hep3B human hepatocellular carcinoma cell line." | 7.79 | Fluoxetine-induced apoptosis in hepatocellular carcinoma cells. ( Kang, HS; Kim, GB; Kim, JS; Kim, SJ; Lee, SJ; Mun, AR, 2013) |
| " In this study, we investigated the effects of fluoxetine, desipramine, and mirtazapine on the liver metastasis of murine C26 colon carcinoma (cc)." | 4.31 | Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines. ( Arteta, B; Curzytek, K; Grygier, B; Kubera, M; Maes, M; Malicki, S, 2023) |
| "Fluoxetine, an antidepressant, has been indicated to elicit anti-cancer response in hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) in vitro." | 3.96 | Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model. ( Chiang, IT; Hsu, FT; Hsu, LC; Tu, HF; Yueh, PF, 2020) |
| "The aim of the present study was to verify the effects of fluoxetine on dysregulation of apoptosis and invasive potential in human hepatocellular carcinoma (HCC) SK-Hep1 and Hep3B cells." | 3.91 | Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro. ( Chen, CH; Chen, WT; Hsu, FT; Hsu, LC; Lin, SS; Liu, YC, 2019) |
| " We investigated the apoptotic effect of fluoxetine against the Hep3B human hepatocellular carcinoma cell line." | 3.79 | Fluoxetine-induced apoptosis in hepatocellular carcinoma cells. ( Kang, HS; Kim, GB; Kim, JS; Kim, SJ; Lee, SJ; Mun, AR, 2013) |
| "Metastasis of hepatocellular carcinoma (HCC) is usually unrecognized before any pathological examination, resulting in time-taking treatment and poor prognosis." | 1.48 | Evaluation of the Inhibitory Effects of Genipin on the Fluoxetine-Induced Invasive and Metastatic Model in Human HepG2 Cells. ( Chen, KC; Hsieh, CL; Maner, RS; Tian, YS; Zulkefli, ND, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kubera, M | 1 |
| Arteta, B | 1 |
| Grygier, B | 1 |
| Curzytek, K | 1 |
| Malicki, S | 1 |
| Maes, M | 1 |
| Hsu, LC | 2 |
| Tu, HF | 1 |
| Hsu, FT | 2 |
| Yueh, PF | 1 |
| Chiang, IT | 1 |
| Tian, YS | 1 |
| Chen, KC | 1 |
| Zulkefli, ND | 1 |
| Maner, RS | 1 |
| Hsieh, CL | 1 |
| Chen, WT | 1 |
| Liu, YC | 1 |
| Chen, CH | 1 |
| Lin, SS | 1 |
| Mun, AR | 1 |
| Lee, SJ | 1 |
| Kim, GB | 1 |
| Kang, HS | 1 |
| Kim, JS | 1 |
| Kim, SJ | 1 |
| Qi, H | 1 |
| Ma, J | 1 |
| Liu, YM | 1 |
| Yang, L | 1 |
| Peng, L | 1 |
| Wang, H | 1 |
| Chen, HZ | 1 |
| Cai, W | 1 |
| Khaoustov, VI | 1 |
| Xie, Q | 1 |
| Pan, T | 1 |
| Le, W | 1 |
| Yoffe, B | 1 |
7 other studies available for fluoxetine and Cancer of Liver
| Article | Year |
|---|---|
Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines.
Topics: Animals; Antidepressive Agents; Carcinoma; Colonic Neoplasms; Cytokines; Desipramine; Fluoxetine; Li | 2023 |
Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model.
Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; C | 2020 |
Evaluation of the Inhibitory Effects of Genipin on the Fluoxetine-Induced Invasive and Metastatic Model in Human HepG2 Cells.
Topics: Carcinoma, Hepatocellular; Fluoxetine; Hep G2 Cells; Humans; Iridoids; Liver Neoplasms; Matrix Metal | 2018 |
Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell P | 2019 |
Fluoxetine-induced apoptosis in hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluoxetine; Humans; Liver Neoplasms; Matrix | 2013 |
Allostatic tumor-burden induces depression-associated changes in hepatoma-bearing mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic | 2009 |
Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiviral Agents; Cell C | 2005 |